Characteristics of intestinal pseudo-obstruction in patients with mitochondrial diseases

World Journal of Gastroenterology

Volumn 18, Issue 33, 2012, Pages 4557-4562

  Sekino, Yusuke ^a   Inamori, Masahiko ^a   Yamada, Eiji ^a   Ohkubo, Hidenori ^a   Sakai, Eiji ^a   Higurashi, Takuma ^a   Iida, Hiroshi ^a   Hosono, Kunihiro ^a   Endo, Hiroki ^a   Nonaka, Takashi ^a   Takahashi, Hirokazu ^a   Koide, Tomoko ^a   Abe, Yasunobu ^a   Gotoh, Eiji ^a   Koyano, Shigeru ^a   Kuroiwa, Yoshiyuki ^a   Maeda, Shin ^a   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Chronic intestinal pseudo obstruction; Chronic progressive external ophthalmoplegia; Criteria; Lactic acidosis; Mitochondrial disease; Mitochondrial encephalopathy; Stroke like episodes

Indexed keywords

ANTIDIARRHEAL AGENT; CHINESE DRUG; DIMETICONE; DISTIGMINE; LAXATIVE; MOSAPRIDE; NEOSTIGMINE; PANTOTHENIC ACID;

ADULT; AGED; ASPIRATION PNEUMONIA; CARDIOMYOPATHY; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CLINICAL ARTICLE; DISEASE DURATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EPILEPSY; FEMALE; HUMAN; INTESTINE PSEUDOOBSTRUCTION; MALE; MEDICAL RECORD REVIEW; MELAS SYNDROME; MERRF SYNDROME; RETROSPECTIVE STUDY; REVIEW; STOMACH CANCER;

EID: 84867722081     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i33.4557     Document Type: Review

References (36)

1. Dudley HA, Sinclair IS, McLaren IF, McNair TJ, Newsam JE. Intestinal pseudo-obstruction. J R Coll Surg Edinb 1958; 3: 206-217
2. Rudolph CD, Hyman PE, Altschuler SM, Christensen J, Colletti RB, Cucchiara S, Di Lorenzo C, Flores AF, Hillemeier AC, McCallum RW, Vanderhoof JA. Diagnosis and treatment of chronic intestinal pseudo-obstruction in children: report of consensus workshop. J Pediatr Gastroenterol Nutr 1997; 24: 102-112
3. Sutton DH, Harrell SP, Wo JM. Diagnosis and management of adult patients with chronic intestinal pseudoobstruction. Nutr Clin Pract 2006; 21: 16-22
4. Connor FL, Di Lorenzo C. Chronic intestinal pseudoobstruction: assessment and management. Gastroenterology 2006; 130: S29-S36
5. Yamanaka Y, Sakakibara R, Asahina M, Uchiyama T, Liu Z, Yamamoto T, Ito T, Suenaga T, Odaka T, Yamaguchi T, Uehara K, Hattori T. Chronic intestinal pseudo-obstruction as the initial feature of pure autonomic failure. J Neurol Neurosurg Psychiatry 2006; 77: 800
6. Anuras S. Intestinal pseudo-obstruction syndrome. Annu Rev Med 1988; 39: 1-15
7. Ogilvie H. Large-intestine colic due to sympathetic deprivation; a new clinical syndrome. Br Med J 1948; 2: 671-673
8. Park JS, Kim HA, Lee KJ, Suh CH. Intestinal pseudoobstruction caused by neuromyopathy in a patient with systemic sclerosis. Mod Rheumatol 2012 Jan 31; Epub ahead of print
9. Masaki T, Sugihara K, Nakajima A, Muto T. Nationwide survey on adult type chronic intestinal pseudo-obstruction in surgical institutions in Japan. Surg Today 2012; 42: 264-271
10. Kim J, Kim N. Intestinal pseudo-obstruction: initial manifestation of systemic lupus erythematosus. J Neurogastroenterol Motil 2011; 17: 423-424
11. Zhang J, Fang M, Wang Y, Mao J, Sun X. Intestinal pseudoobstruction syndrome in systemic lupus erythematosus. Lupus 2011; 20: 1324-1328
12. Hokama A, Kishimoto K, Nakamoto M, Kobashigawa C, Hirata T, Kinjo N, Kinjo F, Kato S, Fujita J. Endoscopic and histopathological features of gastrointestinal amyloidosis. World J Gastrointest Endosc 2011; 3: 157-161
13. Sharma A, Naraynsingh V, Goalan R, Teelucksingh ST. Severe intestinal pseudo-obstruction following withdrawal from over-the-counter steroid abuse. J Postgrad Med 2011; 57: 218-220
14. Young RP, Wu H. Intestinal pseudo-obstruction caused by diltiazem in a neutropenic patient. Ann Pharmacother 2005; 39: 1749-1751
15. Fauville JP, Hantson P, Honore P, Belpaire F, Rosseel MT, Mahieu P. Severe diltiazem poisoning with intestinal pseudo-obstruction: case report and toxicological data. J Toxicol Clin Toxicol 1995; 33: 273-277
16. Camarero-Temiño V, Mercado-Valdivia V, Hijazi-Prieto B, Abaigar-Luquin P. Intestinal pseudo-obstruction secondary to persistent constipation due to lanthanum carbonate. Nefrologia 2012; 32: 129
17. Iida H, Inamori M, Sekino Y, Sakamoto Y, Yamato S, Nakajima A. A review of the reported cases of chronic intestinal pseudo-obstruction in Japan and an investigation of proposed new diagnostic criteria. Clin J Gastroenterol 2011; 4: 141-146
18. Fayssoil A. Heart diseases in mitochondrial encephalomyopathy, lactic acidosis, and stroke syndrome. Congest Heart Fail 2009; 15: 284-287
19. Chiyonobu T, Noda R, Yoshida M, Fujiki A, Ishii R, Nukina S, Fujita K, Goto Y, Morimoto M. Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) associated with phenytoin therapy. Brain Dev 2008; 30: 430-433
20. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 2003; 348: 2656-2668
21. Pulkes T, Liolitsa D, Eunson LH, Rose M, Nelson IP, Rahman S, Poulton J, Marchington DR, Landon DN, Debono AG, Morgan-Hughes JA, Hanna MG. New phenotypic diversity associated with the mitochondrial tRNA(SerUCN) gene mutation. Neuromuscul Disord 2005; 15: 364-371
22. Hanna MG, Nelson IP. Genetics and molecular pathogenesis of mitochondrial respiratory chain diseases. Cell Mol Life Sci 1999; 55: 691-706
23. Garone C, Tadesse S, Hirano M. Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain 2011; 134: 3326-3332
24. Giordano C, d'Amati G. Evaluation of gastrointestinal mtDNA depletion in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Methods Mol Biol 2011; 755: 223-232
25. Granero Castro P, Fernández Arias S, Moreno Gijón M, Alvarez Martínez P, Granero Trancón J, Álvarez Pérez JA, Lamamie Clairac E, González González JJ. Emergency surgery in chronic intestinal pseudo-obstruction due to mitochondrial neurogastrointestinal encephalomyopathy: case reports. Int Arch Med 2010; 3: 35
26. Oztas E, Ozin Y, Onder F, Onal IK, Oguz D, Kocaefe C. Chronic intestinal pseudo-obstruction and neurological manifestations in early adulthood: considering MNGIE syndrome in differential diagnosis. J Gastrointestin Liver Dis 2010; 19: 195-197
27. Chinnery PF, Turnbull DM. Mitochondrial medicine. QJM 1997; 90: 657-667
28. Amiot A, Tchikviladzé M, Joly F, Slama A, Hatem DC, Jardel C, Messing B, Lombès A. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. Gastroenterology 2009; 137: 101-109
29. Gilbert J, Ibdah JA. Intestinal pseudo-obstruction as a manifestation of impaired mitochondrial fatty acid oxidation. Med Hypotheses 2005; 64: 586-589
30. Betts J, Barron MJ, Needham SJ, Schaefer AM, Taylor RW, Turnbull DM. Gastrointestinal tract involvement associated with the 3243A& gt; G mitochondrial DNA mutation. Neurology 2008; 70: 1290-1292
31. Parsons T, Weimer L, Engelstad K, Linker A, Battista V, Wei Y, Hirano M, Dimauro S, De Vivo DC, Kaufmann P. Autonomic symptoms in carriers of the m.3243A> G mitochondrial DNA mutation. Arch Neurol 2010; 67: 976-979
32. Bariş Z, Eminoǧlu T, Dalgiç B, Tümer L, Hasanoǧlu A. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): case report with a new mutation. Eur J Pediatr 2010; 169: 1375-1378
33. Hirano M, Nishino I, Nishigaki Y, Martí R. Thymidine phosphorylase gene mutations cause mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Intern Med 2006; 45: 1103
34. Slama A, Lacroix C, Plante-Bordeneuve V, Lombès A, Conti M, Reimund JM, Auxenfants E, Crenn P, Laforêt P, Joannard A, Seguy D, Pillant H, Joly P, Haut S, Messing B, Said G, Legrand A, Guiochon-Mantel A. Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome. Mol Genet Metab 2005; 84: 326-331
35. Glia A, Akerlund JE, Lindberg G. Outcome of colectomy for slow-transit constipation in relation to presence of smallbowel dysmotility. Dis Colon Rectum 2004; 47: 96-102
36. Makino M, Nonaka I. Epidemiology of mitochondrial disease. Annual Review Shinkei 1999: 406-412